Valuation: Crossject

Market Cap 8.24Cr 9.49Cr 7.68Cr 7.06Cr 13Cr 904.59Cr 14Cr 91Cr 36Cr 450.89Cr 36Cr 35Cr 1.49TCr P/E 2026 *
3.69x
P/E 2027 * 2.91x
Enterprise Value 6.45Cr 7.43Cr 6.02Cr 5.53Cr 10Cr 708.15Cr 11Cr 71Cr 28Cr 352.97Cr 28Cr 27Cr 1.17TCr EV / Sales 2026 *
1.06x
EV / Sales 2027 * 0.84x
Free-Float
90.34%
Yield 2026 *
-
Yield 2027 * -
1 day+0.93%
1 week+0.66%
Current month+0.93%
1 month-15.32%
3 months-20.48%
6 months-25.42%
Current year-30.87%
1 week 1.48
Extreme 1.476
1.6
1 month 1.46
Extreme 1.462
1.8
Current year 1.46
Extreme 1.462
2.58
1 year 1.35
Extreme 1.346
2.7
3 years 0.72
Extreme 0.7199
5.96
5 years 0.72
Extreme 0.7199
5.96
10 years 0.72
Extreme 0.7199
8.36
Manager TitleAgeSince
Chief Executive Officer 63 08/08/2001
Director of Finance/CFO - 25/03/2026
Corporate Officer/Principal - 20/08/2024
Director TitleAgeSince
Chairman 67 26/06/2009
Director/Board Member 67 -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
04/07/25 Buy

Director

13,386 0.0266%
01/07/25 Buy

Director

50 0.0001%
01/07/25 Buy

Director

337 0.0007%
Change 5-day change 1-year change 3-year change Capi.($)
+0.93%+0.66%-4.30%-59.08% 9.39Cr
+2.65%+16.03%-35.01%-54.68% 10Cr
-2.80%+13.49%+101.69%+10.77% 8.3Cr
Average +0.26%+9.84%+20.79%-34.33% 9.3Cr
Weighted average by Cap. +0.45%+9.66%+16.00%-36.69%

Financials

2026 *2027 *
Net sales 6.08Cr 7Cr 5.67Cr 5.21Cr 9.83Cr 667.24Cr 10Cr 67Cr 26Cr 332.58Cr 26Cr 26Cr 1.1TCr 4.23Cr 4.87Cr 3.94Cr 3.62Cr 6.84Cr 464.21Cr 6.96Cr 47Cr 18Cr 231.38Cr 18Cr 18Cr 766.07Cr
Net income 2.83Cr 3.26Cr 2.64Cr 2.43Cr 4.57Cr 310.57Cr 4.65Cr 31Cr 12Cr 154.8Cr 12Cr 12Cr 512.52Cr 77.5L 89.2L 72.25L 66.42L 1.25Cr 85Cr 1.27Cr 8.53Cr 3.34Cr 42Cr 3.35Cr 3.28Cr 140.35Cr
Net Debt -1.79Cr -2.06Cr -1.67Cr -1.53Cr -2.89Cr -196.44Cr -2.94Cr -20Cr -7.72Cr -98Cr -7.74Cr -7.56Cr -324.17Cr -4.7Cr -5.41Cr -4.38Cr -4.03Cr -7.6Cr -515.79Cr -7.73Cr -52Cr -20Cr -257.09Cr -20Cr -20Cr -851.18Cr
Logo Crossject
Crossject specializes in manufacturing and marketing needleless drug self-injection. The group provides Zeneo, a prefilled and single-use device that can be used for intradermal, subcutaneous and intramuscular injections.
Employees
99
Date Price Change Volume
03/26/03 €1.514 +0.93% 1,96,128
31/26/31 €1.500 0.00% 3,41,986
30/26/30 €1.500 +0.67% 1,34,890
29/26/29 €1.490 -0.67% 1,64,996
28/26/28 €1.500 0.00% 1,14,470
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.514EUR
Average target price
4.400EUR
Spread / Average Target
+190.62%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALCJ Stock